22 Dec 2025

Shardul Amarchand Mangaldas advises Medi Assist on ₹198 crore preferential equity raise

"Shardul Amarchand Mangaldas & Co advised Medi Assist Healthcare Services Limited on a ~₹198 crore preferential allotment of fully paid equity shares to Massachusetts Institute of Technology and 238 Plan Associates LLC. The investors are qualified institutional buyers and SEBI-registered foreign portfolio investors; post-issue MIT holds 3.86% and 238 Plan Associates holds 1.08% of Medi Assist."

Shardul Amarchand Mangaldas & Co advised Medi Assist Healthcare Services Limited in a preferential equity issuance to Massachusetts Institute of Technology and 238 Plan Associates LLC. Medi Assist Healthcare Services Limited raised approximately ₹198 crore through a preferential issue and allotment of fully paid-up equity shares to the two investors. The allotment was made on a preferential basis to qualified institutional buyers and SEBI-registered foreign portfolio investors. Following the preferential issue, the Massachusetts Institute of Technology holds 3.86% and 238 Plan Associates LLC holds 1.08% of the total share capital of Medi Assist. Shardul Amarchand Mangaldas & Co represented Medi Assist Healthcare Services Limited with a team composed by: Prashant Gupta (National Practice Head – Capital Markets), Devesh Pandey (Partner), Jasmine Khan (Senior Associate), Anushka Ganguli (Associate) and Sourav Paul (Associate).
Read the full story

Register for free to access daily news.

Register Free